Cargando…
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
BACKGROUND: Alzheimer’s (AD) and Parkinson’s diseases (PD) show deposits of improperly folded modified proteins. Protein expression mechanisms are involved since the early stages. Several studies evaluated epigenomics and proteomics profiles in these patients, with promising results. In general, the...
Autores principales: | Mayo, Sonia, Benito-León, Julián, Peña-Bautista, Carmen, Baquero, Miguel, Cháfer-Pericás, Consuelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719284/ https://www.ncbi.nlm.nih.gov/pubmed/33357195 http://dx.doi.org/10.2174/1570159X19666201223154009 |
Ejemplares similares
-
Lipids as Early and Minimally Invasive Biomarkers for Alzheimer’s Disease
por: Casas-Fernández, Esther, et al.
Publicado: (2022) -
Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages
por: Peña-Bautista, Carmen, et al.
Publicado: (2021) -
Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
por: Ferré-González, Laura, et al.
Publicado: (2022) -
Early neurotransmission impairment in non-invasive Alzheimer Disease detection
por: Peña-Bautista, Carmen, et al.
Publicado: (2020) -
Oxidative Damage of DNA as Early Marker of Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2019)